Suchergebnisse - "Laroni, Alice"

PubPharm (7)

1

SARS-CoV-2 vaccination and multiple sclerosis : a large multicentric study on relapse risk after the third booster dose

enthalten in: Journal of neurology | 2024

von Di Filippo, M. | Ferraro, D. | Ragonese, P. | +26

2

Antibody response elicited by the SARS-CoV-2 vaccine booster in patients with multiple sclerosis : Who gains from it?

enthalten in: European journal of neurology | 2023

von Schiavetti, I. | Inglese, M. | Frau, J. | +94

3

CD19+ B cell values predict the increase of anti-SARS CoV2 antibodies in fingolimod-treated and COVID-19-vaccinated patients with multiple sclerosis

enthalten in: Multiple sclerosis and related disorders | 2023

von Schiavetti, I. | Barcellini, L. | Lapucci, C. | +8

4

Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies

enthalten in: Multiple sclerosis (Houndmills, Basingstoke, England) | 2022

von Schiavetti, I. | Cordioli, C. | Stromillo, M. | +26

5

Breakthrough SARS-CoV-2 infections after COVID-19 mRNA vaccination in MS patients on disease modifying therapies during the Delta and the Omicron waves in Italy

enthalten in: EBioMedicine | 2022

von Sormani, M. | Schiavetti, I. | Inglese, M. | +117

6

mRNA COVID-19 vaccines do not increase the short-term risk of clinical relapses in multiple sclerosis

enthalten in: Journal of neurology, neurosurgery, and psychiatry | 2022

von Di Filippo, M. | Cordioli, C. | Malucchi, S. | +30

CommentIn: Nat Rev Neurol. 2021 Oct;17(10):595. - PMID 34475567

7

Effect of SARS-CoV-2 mRNA vaccination in MS patients treated with disease modifying therapies

enthalten in: EBioMedicine | 2021

von Sormani, M. | Inglese, M. | Schiavetti, I. | +115

CommentIn: J Neurol. 2022 Apr;269(4):2259-2261. - PMID 35286479

1
[1]